 |
| Overview |
Certifications/Recognitions |
• |
Unique Business Model |
• |
Disease Focus |
• |
Intellectual property & proprietary know-how based product basket |
• |
Range of Specialty Products – one of few manufacturers worldwide |
• |
World-class Manufacturing facilities |
• |
International quality standards and certifications |
• |
Large scale manufacturing capacities |
• |
Enjoying significant cost advantage |
• |
Product development and regulatory capabilities |
• |
Global Brands |
• |
Market Leadership |
• |
Extensive Sales & Distribution network |
• |
Highly respected among medical fraternity |
|
• |
Accepted by international regulatory authorities including USFDA, MHRA(UK), TGA (Australia), NAM (National Agency for Medicine) Finland, GCC (Gulf Co-operation Council), ANVISA (Agencia Nacional de Vigilancia Sanitaria), INVIMA (Instituto Nacional de Vigilancia de Medicamentos Y Alimentos) |
• |
“IDMA” Quality Excellence Award for 2nd Consecutive year |
• |
Certified for ISO 9001:2000 |
|
| |
| Businesses |
| Businesses |
Market Presence |
• |
Clinical Nutrition |
• |
Anesthesia |
• |
Plasma Volume Expanders |
• |
Blood Products |
• |
Advanced Anti-infectives |
• |
Renal & Transplant |
• |
Oncology |
• |
Infusion therapy |
• |
Disposables & Equipment |
• |
Pharmaceutical Generics |
|
• |
Presence in 76 countries across Latin America, Europe, Gulf, Africa, CIS, Central Asia and Asia- Pacific |
• |
Subsidiary companies, laboratories, office infrastructure |
• |
Grass root marketing & brand building |
• |
Supplier to aid agencies |
|
| Competitive Edge |
• |
1st to introduce several products in India |
• |
No single Indian company having similar product focus |
• |
Few International players |
• |
Extensive S&D network |
|
| Manufacturing |
Capabilities |
| • |
World class facilities designed to produce aqueous and oil based products. |
| • |
Contract Manufacturing Capabilities |
| • |
Bags |
| |
|
PVC/Non-PVC |
| |
|
Multi-chamber bags |
| |
|
Double bag systems |
| • |
Glass containers |
| |
|
Bottles |
| |
|
Vials |
| |
|
Ampoules |
| • |
Aseptic manufacturing |
| |
|
Liquid form |
| |
|
Oral Form |
| • |
Lyophilization |
| • |
Prefilled syringes |
| |
|
Glass |
| |
|
Plastic |
| • |
Liposomal technology |
| • |
Soft gelatin capsules |
| • |
Blow-Fill-Seal Blow-Fill-Seal |
| Quality |
“Would we use it to treat our dearest ones?”
If the answer is an unhesitant “Yes,”
The product has passed our final quality test.
We call this “Emotional Pharmacopoeia.” |
|
Regulatory |
• |
Trained and committed manpower for regulated/non-regulated markets, IPR and Clinical trial studies. |
• |
Sound and complete understanding of International Regulatory Requirements |
• |
Successfully attained key international regulatory approvals including USFDA, MHRA(UK), TGA (Australia), NAM (National Agency for Medicine) Finland, GCC (Gulf Co-operation Council), ANVISA (Agencia Nacional de Vigilancia Sanitaria), INVIMA (Instituto Nacional de Vigilancia de Medicamentos Y Alimentos) |
• |
Submitted over 1532 dosiers. |
• |
Marketing Authorisation applications filed in several regulated markets. |
|
| R & D |
• |
New Products |
|
|
Formulation Development |
|
|
Outsourcing components |
|
|
Alliances |
• |
New concepts development ( eg. PNA™) |
• |
New Drug Delivery Systems |
|
|
Two Platforms |
|
|
|
Lipid based D D S |
|
|
|
Liposomal D D S |
• |
Development of API with DMF source |
• |
Contract Research |
| • |
Team of experienced scientists. |
| • |
Full fledged center with advanced equipment |
| • |
Drug Delivery Systems |
| • |
Active Pharmaceutical Ingredients (APIs) |
|
| |
| Major Platforms |
• |
Fat Emulsion Technology |
• |
Liposomes |
• |
Biotechnology |
|
| |
|
| |
